Latest Breaking News On - ப்ரொஃபெஸர் பியோனா மரம் - Page 1 : comparemela.com

Pharmaxis Ltd has multiple potential value inflection points with two drugs advancing in clinical trials

Pharmaxis Ltd (ASX:PXS) (FRA:UUD) has multiple potential value inflection points over the next two years, with two drugs in clinical trials that are due to report meaningful efficacy and safety endpoints in patients by the end of 2022. The company has a platform technology that has delivered a pipeline of first in class or best in class clinical drugs for inflammatory and fibrotic diseases. The first of these drugs already has an IND approval from the FDA and is currently being trialled in myelofibrosis patients. Its lead asset PXS-5505 – with disease-modifying potential in myelofibrosis – is in Phase 1c/2 trial, with further collaborations to extend the value of PXS-5505 in a variety of other oncology indications where there is strong unmet need.

New yorkUnited statesBoston universityNew south walesFrenchs forestGary phillipsKatya ravidSchool of biomedical sciences dr kylie sandyProfessor of biology at boston universityDrug administrationBoston university school of medicineUniversity of western australiaDrugs administrationSenior researchChiesi united states incNational heart

World-first trial for Australian company Pharmaxis

(ASX:PSX) has announced a partnership to launch a world-first clinical trial that aims to stop scars from forming after trauma, particularly following burn injuries. The company is partnering with distinguished surgeon and burns expert Professor Fiona Wood AM who is leading a group of researchers from the University of Western Australia (UWA) and Fiona Stanley Hospital to test a treatment in the first human trials. Pharmaxis said its discovery, known as PXS‐6302, has shown promising pre‐clinical results in inhibiting the enzymes that play a critical role in the development of scar tissue. PXS‐6302 was discovered by the company’s researchers at its laboratories in Sydney.

New south walesGary phillipsKylie sandySchool of biomedical sciencesUniversity of western australiaProfessor fiona woodWestern australiaFiona stanley hospitalBiomedical sciencesBiotechnology industrySenior research fellowResearch fellowClinical trialWound healingபுதியது தெற்கு வேல்ஸ்கேரி பிலிப்ஸ்

Pharmaxis details world-first clinical trial of treatment to prevent wound and burn scars

Pharmaxis details world-first clinical trial of treatment to prevent wound and burn scars
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Gary phillipsAndrew scottUniversity of western australiaProfessor fiona woodWestern australiaFiona stanley hospitalகேரி பிலிப்ஸ்ஆண்ட்ரூ ஸ்காட்பல்கலைக்கழகம் ஆஃப் மேற்கு ஆஸ்திரேலியாப்ரொஃபெஸர் பியோனா மரம்மேற்கு ஆஸ்திரேலியாபியோனா ஸ்டான்லி மருத்துவமனை

Pharmaxis details world-first clinical trial of treatment to prevent wound and burn scars

Pharmaxis details world-first clinical trial of treatment to prevent wound and burn scars
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.